Excerpted from "Reduction of
Drug Residues: Applications in Drug Rehabilitation," a
presentation to the 123rd Annual Meeting of the American
Public Health Association. Authors: Megan Shields, M.D.;
F. Tennant, M.D., Dr. P.H.; Shelley Beckmann, Ph.D.; and
R. Michael Wisner.
It is increasingly evident
that the accumulation of drug residues and their
lipophilic metabolites in the body plays a role in drug
addiction. Such residues are associated with persistent
symptoms and their mobilization from body stores into
blood correlates with drug craving.
A detoxification method
developed by L. Ron Hubbard was specifically
targeted at reducing levels of fat-stored chemical
residues in the body and thereby alleviating the
long-term effects of such compounds. We were interested
in determining whether drugs were eliminated during this
program and, if so, what types of symptom changes
occurred as a consequence.
The concentration of drug
metabolites in both sweat and urine was measured in
eight clients who had been actively using drugs prior to
treatment with Mr. Hubbard's program. Treatment occurred
at the Narconon drug rehabilitation center in Los
Angeles.
Cocaine, amphetamine and
benzodiazepine metabolites were detected by fluorescent
immunoassay in both sweat and urine of these clients.
Following start of treatment, metabolite concentration
increased in either sweat or urine in five cases. In two
cases the level of drug was below detection prior to
treatment but became detectable while doing the
detoxification program. Drugs continued to be eliminated
for up to five weeks.
A separate series of 249
clients with a history of drug abuse rated the severity
of their symptoms before and after treatment with Mr.
Hubbard's program. Prior to treatment, their chief
symptomatic complaints included fatigue, irritability,
depression, intolerance of stress, reduced attention
span and decreased mental acuity. These same symptoms
were dominant in those who had ceased active drug abuse
over a year prior to treatment. Following treatment,
both past and current users reported marked improvements
in symptoms with most returning to normal range. This
detoxification program represents a vital innovation in
drug rehabilitation: an approach aimed at a long-term
reduction of the predisposition for drug abuse.
Background
Residues of many drugs
including LSD, phencyclidine (PCP), cocaine, marijuana
and diazepam (Valium) are known to accumulate in the
body. These compounds may be retained for extended
periods of time, and are especially abundant in
long-term, hard-core drug users.
Persistent symptoms
associated with drug abuse often linger long after abuse
has ceased.
The consideration that
accumulated residues may play a role in the persistence
of symptoms led L. Ron Hubbard to develop a program
aimed at reducing levels of foreign compounds in the
body and thereby assisting in the recovery of the
individual.
This detoxification program
is one component of the Narconon drug rehabilitation
program. It has been empirically observed that clients
are more alert and do better on the balance of the
Narconon program after completing the detoxification
component.
We were interested in
evaluating the effects of the detoxification program on
both the elimination of drug metabolites and the
alleviation of symptomatic complaints.
Therefore, we measured the
levels of various drug metabolites in both sweat and
urine over the course of the detoxification program in
eight clients with long-term drug abuse problems.
We also monitored the change
in severity of self-reported symptoms in a series of 249
clients with a history of drug abuse who were treated
with this detoxification program. Elements of the Detoxification
Program
The detoxification program
developed by Hubbard is aimed at mobilizing and
eliminating foreign compounds, especially those stored
in the fat. Components include:
A. Exercise, preferably
running, to stimulate circulation and enhance the
turnover of fats.
B. Prescribed periods in a
low temperature sauna to promote sweating.
C. An exact regimen of
vitamin, mineral and oil intake. Niacin in gradually
increasing doses is used to transiently increase fat
mobilization. Oil supplementation both reduces
enterohepatic (reabsorption into the live) recirculation
and promotes the exchange of fat. Vitamin and mineral
supplements are included to replace vitamins, minerals
and electrolytes lost during increased sweating and to
correct any nutritional deficiencies.
D. Sufficient liquids to
offset the loss of body fluids through sweating.
E. A regular diet including
plenty of fresh vegetables.
F.A properly ordered
personal schedule which provides the person with the
normally required amount of sleep.
Clients are on this program
up to 5 hours per day, every day, until program
completion. Daily aerobic exercise is followed by
frequent periods of low-heat (60º-80º C) sauna. Niacin
is administered immediately prior to the exercise and
sauna to assist with the mobilization and elimination
process. The program is pursued individually until a
stable clinical improvement is achieved, generally from
14 to 28 days.
Treatment
Population
249 clients with a history
of drug abuse rated the severity of their symptoms
before and after treatment with the detoxification
program. 87 symptoms were rated on a scale of 0 (none)
to 5 (severe).
These clients could be
divided into one or more subgroups:
A. 59 clients who were
doing the detoxification program as part of a drug
rehabilitation program;
B. 152 clients who had
used drugs recently but were occasional drug users
without marked addiction; and
C. 49 clients whose last
reported use of drugs was from one to ten years prior
to the detoxification program. Sample Collection
for Drug Measurement
Eight clients with a
current drug addiction problem agreed to contribute
urine and sweat samples as they went through both
withdrawal (if needed) and the detoxification program.
Four had smoked cocaine
almost daily and had been using cocaine from eight
months to 18 years prior to treatment. Three were
frequent users of amphetamines and Valium (diazepam).
One used cocaine and heroin.
Urine and sweat samples
were collected on program entry and every two to three
days during the detoxification program.
The concentration of drug
residues in urine and sweat samples was determined by
the polarized fluorescent immunoassay (PIF) technique
at a 95 percent sensitivity of approximately 25 ng/mL.
Results
Symptom Severity
Clients reported the
severity of symptoms both before and after
detoxification treatment. Irritability, fatigue,
depression, intolerance of stress, reduced attention
span, decreased mental acuity, nervousness and
impaired memory were the main complaints of these
clients. (Table 1)
The symptom profile for
current users is compared to the profile for past
users in Figure 1. Though the severity is higher for
symptoms in current users, the complaints overlap
remarkably in the two groups. This strongly supports
the concept that persistent symptoms in the general
population are related to past drug use.
Following treatment, the
self-reported symptom severity improved markedly
(Figure 2). The reduction in symptom severity was
statistically significant for 80 of the 87 symptoms,
and highly significant for 74 of them, including each
of the chief complaints of this population.
Drug
Metabolites in Sweat and Urine
Drug metabolites were found in both sweat and
urine for seven of the eight clients participating in
this study. Five of the eight clients showed an
increase in the concentration of drug metabolite in
sweat or urine when the detoxification program was
initiated.
Drug metabolites were not
detected in the urine of two clients before the start
of detoxification treatment but were detected after
the program began. This supports the argument that
drug metabolites were mobilized from stores.
Drug metabolites were
detectable in both sweat and urine for up to five
weeks following the start of detoxification treatment.
(See following graphs.)
Discussion
The detoxification method
developed by L. Ron Hubbard has previously been
shown safe and effective in reducing levels of various
chemicals in humans, including polychlorinated
biphenyls (PCBs) and pesticides, and in decreasing the
adverse signs and symptoms associated with exposure to
these chemicals.
Use of this detoxification
program at Narconon is based on the premise that drug
residues remain in body tissues long after active use
has ceased and that these residues contribute to both
persistent symptoms and the craving for drugs.
This study demonstrates
that the detoxification program developed by Hubbard
is effective in alleviating many of the symptomatic
complaints reported by drug users.
Cocaine, amphetamine and
benzodiazepine metabolites are found in both the urine
and the sweat of individuals who have used these drugs
as they undergo detoxification treatment.
Individuals report marked
reductions in drug craving following this program.
Considering the high level
of recidivism in drug users, the potential effects of
drug residues on recidivism, and the alleviation of
these effects through detoxification, it becomes
evident that detoxification treatment has broad
application in the drug rehabilitation field.
|